Key Insights

Highlights

Success Rate

74% trial completion

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 49/100

Termination Rate

11.5%

7 terminated out of 61 trials

Success Rate

74.1%

-12.4% vs benchmark

Late-Stage Pipeline

13%

8 trials in Phase 3/4

Results Transparency

50%

10 of 20 completed with results

Key Signals

10 with results74% success

Data Visualizations

Phase Distribution

51Total
Not Applicable (23)
Early P 1 (3)
P 1 (3)
P 2 (14)
P 3 (3)
P 4 (5)

Trial Status

Completed20
Recruiting17
Terminated7
Unknown6
Withdrawn6
Not Yet Recruiting2

Trial Success Rate

74.1%

Benchmark: 86.5%

Based on 20 completed trials

Clinical Trials (61)

Showing 20 of 20 trials
NCT05149573Not ApplicableRecruiting

Investigation of PEMF Therapy for Female Patients With IC/BPS

NCT06204874Not ApplicableRecruitingPrimary

New Approaches to Nerve Stimulation Therapy for Bladder Pain Syndrome

NCT05658874Phase 3Terminated

A Multidisciplinary, Multimodal Bundled Care Approach to Chronic Pelvic Pain

NCT06013449Not ApplicableNot Yet Recruiting

Efficacy of Pulsed Electromagnetic Field and Heparin/Bupivacaine Instillations

NCT07459790Phase 2Recruiting

The Study is Being Conducted to Find a New Treatment for Patients Suffering From Interstitial Cystitis With Hunner's Lesions

NCT02591199Phase 2Terminated

Engage 24: Evaluation of the Safety and Effectiveness of URG101 in Subjects With Interstitial Cystitis/Bladder Pain Syndrome

NCT05127616Not ApplicableRecruiting

EPPIC: Easing Pelvic Pain Interventions Clinical Research Program

NCT05737121Phase 2Recruiting

Safety and Efficacy Study of VNX001 Compared to Its Individual Components (Lidocaine and Heparin) or Placebo in Subjects With IC/BPS

NCT06394830Phase 2Recruiting

Safety, Efficacy, and Frequency of Administration of VNX001 in the Treatment of Interstitial Cystitis / Bladder Pain Syndrome (IC/BPS)

NCT06299683Not ApplicableRecruiting

Pain Type and Interstitial Cystitis/Bladder Pain Syndrome Treatment

NCT06366269Not ApplicableRecruitingPrimary

Acupuncture First for IC/BPS

NCT00389142Recruiting

Identifying Genetic Causes of IC/BPS

NCT06212661Enrolling By Invitation

Migraine Medication Effects on Urinary Symptoms

NCT05699551Not ApplicableWithdrawn

Supervised Exercise as a Therapeutic Strategy for Interstitial Cystitis/Bladder Pain Syndrome

NCT04734106Early Phase 1Recruiting

Safety and Efficacy of Aloe Vera in the Management of the Symptoms of Interstitial Cystitis

NCT06863220Not ApplicableNot Yet Recruiting

Intravesical Ozone Therapy for Interstitial Cystitis/Bladder Pain Syndrome

NCT06232200Not ApplicableCompleted

Investigation of the Effectiveness of Acupuncture in Patients Diagnosed With Interstitial Cystitis

NCT04313972Phase 4Terminated

IC PaIN Trial: Interstitial Cystitis Pain Improvement With Naltrexone

NCT05740007Phase 2Terminated

A Phase 2 Study of IW-3300 for the Treatment of Bladder Pain in Subjects With Interstitial Cystitis/Bladder Pain Syndrome

NCT06387329Phase 4Recruiting

Bladder Botox UTI Antibiotic Prophylaxis

Scroll to load more

Research Network

Activity Timeline